Toll Free: 1-888-928-9744
Published: May, 2017 | Pages:
75 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global biopsy devices market size is expected to reach USD 2.3 billion by 2020, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.4% during the forecast period. Growing incidence of cancer, rising geriatric population across the world, and soaring demand for less invasive biopsy procedures are some of the key trends stimulating market growth. Demand for minimally invasive biopsy procedures is rising at a significant rate in the market. Different types of technologies and products such as, biopsy guiding systems, needle-based biopsy guns, and vacuum assisted devices are anticipated to witness high growth during the forecast period. North America is likely to command a considerable revenue share in the market throughout the forecast period. On the other hand, Asia Pacific is projected to post a noteworthy CAGR during the same period. In emerging economies, high price of biopsy devices can hinder the growth of the market. Patients in the countries are generally price sensitive and need more efficient and effective medical technologies and facilities. There are several regulatory changes coming across the world to address unmet needs of patients in these areas. High unmet patient needs coupled with rapidly improving healthcare infrastructure in emerging countries such as India and China are poised to augment the regional market. Advent of technologically advanced and efficient products such as Vacora and Finesse Ultra Breast Biopsy System by BARD and Celero VAB device by Hologic Inc. is stoking the growth of the market. Besides this, burgeoning popularity of these devices in developed countries such as the U.S., Canada, and Japan are expected to boost the growth of the overall market during the forecast period. Some of the key players in the biopsy devices market are Inard Inc.; Carefusion Corporation; Devicor Medical Products, Inc; DTR Medical; Hologic Inc.; C.R. Bard Inc. and Cardinal Health Inc. These companies are involved in developing and adding technologically advanced and cost effective instruments to their product portfolio. Further key findings from the report suggest: • Due to rapid technological advancements and high efficiency, biopsy guidance systems are anticipated to register sharp rise in their demand over the forecast period • Surging demand for less invasive surgeries and disposable biopsy devices is one of the primary growth stimulants for the market • Technologies such as vacuum assisted biopsy devices are able to facilitate easy removal of large tissue samples. Upsurge in their demand will influence the overall market positively • The North America market was at the forefront of the market. The region is driven by various factors such as better infrastructure, patient awareness, and good healthcare facilities • Asia Pacific is estimated to emerge as the fastest growing region in the global arena.
Table of Contents Chapter 1 Executive Summary Chapter 2 Biopsy Devices Industry Outlook 2.1 Market Segmentation 2.2 Market size and growth prospects 2.3 Biopsy devices - Market dynamics 2.3.1 Market Driver Analysis 2.3.1.1 Growing prevalence of cancer 2.3.1.2 Growing global geriatric population base 2.3.1.3 Increasing demand for minimally invasive medical procedures 2.3.1.4 Growing cancer related spending triggering the need for effective diagnostic procedures 2.3.2 Market Restraint Analysis 2.3.2.1 High product prices 2.4 Key Opportunities Prioritized 2.5 Industry Analysis - Porter's 2.6 Biopsy devices - PESTEL Analysis 2.7 Company market share analysis Chapter 3 Biopsy Devices Product Outlook 3.1 Biopsy devices market share by product, 2013 & 2020 3.2 Needle based biopsy guns 3.2.1 Needle based biopsy guns' market, 2012 - 2020 (USD Million) 3.2.2 Vacuum-assisted biopsy (VAB) devices 3.2.2.1 Vacuum-assisted biopsy (VAB) devices market, 2012 - 2020 (USD Million) 3.2.3 Fine needle aspiration biopsy (FNAB) devices 3.2.3.1 Fine needle aspiration biopsy (FNAB) devices market, 2012 - 2020 (USD Million) 3.2.4 Core needle biopsy (CNB) devices 3.2.4.1 Core needle biopsy (CNB) devices market, 2012 - 2020 (USD Million) 3.3 Biopsy guidance systems 3.3.1 Biopsy guidance systems market, 2012 - 2020 (USD Million) 3.3.2 Manual guidance system 3.3.2.1 Manual guidance system market, 2012 - 2020 (USD Million) 3.3.3 Robotic guidance system 3.3.3.1 Robotic guidance system market, 2012 - 2020 (USD Million) 3.4 Biopsy needles 3.4.1 Biopsy needles market, 2012 - 2020 (USD Million) 3.4.2 Disposable biopsy needles 3.4.2.1 Disposable biopsy needles market, 2012 - 2020 (USD Million) 3.4.3 Reusable biopsy needles 3.4.3.1 Reusable biopsy needles market, 2012 - 2020 (USD Million) 3.5 Biopsy forceps 3.5.1 Biopsy forceps market, 2012 - 2020 (USD Million) 3.5.2 Cold/General biopsy forceps 3.5.2.1 General biopsy forceps market, 2012 - 2020 (USD Million) 3.5.3 Hot biopsy forceps 3.5.3.1 Hot biopsy forceps market, 2012 - 2020 (USD Million) 3.6 Other biopsy devices 3.6.1 Other biopsy devices Market, 2012 - 2020 (USD Million) 3.6.2 Brushes 3.6.2.1 Biopsy brushes market, 2012 - 2020 (USD Million) 3.6.3 Curettes 3.6.3.1 Biopsy curettes market, 2012 - 2020 (USD Million) 3.6.4 Punches 3.6.4.1 Biopsy punches market, 2012 - 2020 (USD Million) Chapter 4 Biopsy Devices Regional Outlook 4.1 Biopsy devices market share, by region, 2013 & 2020 4.2 North America biopsy devices market 4.2.1 North America biopsy devices market, by product, 2012 - 2020 (USD Million) 4.3 Europe biopsy devices market 4.3.1 Europe biopsy devices market, by product, 2012 - 2020 (USD Million) 4.4 Asia Pacific biopsy devices market 4.4.1 Asia Pacific biopsy devices market, by product, 2012 - 2020 (USD Million) 4.5 LatAM & MEA biopsy devices market 4.5.1 RoW biopsy devices market, by product, 2012 - 2020 (USD Million) Chapter 5 Competitive Landscape 5.1 Angiotech (Surgical Specialties Corporation) 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 Cardinal Health Inc. 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Carefusion Corporation 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 C.R. Bard Inc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 Devicor Medical Products Inc. 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 DTR Medical 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Hologic, Inc 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 INRAD, Inc 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking Chapter 6 Methodology and Scope 6.1 Research Methodology 6.2 Research Scope & Assumptions 6.3 List of Data Sources
List of Tables TABLE 1 Biopsy Devices Market - Industry Summary & Critical Success Factors (CSFs) TABLE 2 Global biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 3 Global biopsy devices market, by region, 2012 - 2020 (USD Million) TABLE 4 Biopsy devices - Key market driver analysis TABLE 5 Global cancer statistics, 2012 (in Millions) TABLE 6 U.S. cancer incidence, 2013, by age-group TABLE 7 Biopsy devices - Key market restraint analysis TABLE 8 U.S. estimated number of new cancer cases, by site, 2013 TABLE 9 North America biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 10 North America needle based biopsy guns' market, by product, 2012 - 2020 (USD Million) TABLE 11 North America biopsy guidance systems market, by product, 2012 - 2020 (USD Million) TABLE 12 North America biopsy needles market, by product, 2012 - 2020 (USD Million) TABLE 13 North America biopsy forceps market, by product, 2012 - 2020 (USD Million) TABLE 14 North America other biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 15 Europe cancer incidence, by site, 2012 (Thousands) TABLE 16 Europe biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 17 Europe needle based biopsy guns' market, by product, 2012 - 2020 (USD Million) TABLE 18 Europe biopsy guidance systems market, by product, 2012 - 2020 (USD Million) TABLE 19 Europe biopsy needles market, by product, 2012 - 2020 (USD Million) TABLE 20 Europe biopsy forceps market, by product, 2012 - 2020 (USD Million) TABLE 21 Europe other biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 22 Asia Pacific biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 23 Asia Pacific needle based biopsy guns' market, by product, 2012 - 2020 (USD Million) TABLE 24 Asia Pacific biopsy guidance systems market, by product, 2012 - 2020 (USD Million) TABLE 25 Asia Pacific biopsy needles market, by product, 2012 - 2020 (USD Million) TABLE 26 Asia Pacific biopsy forceps market, by product, 2012 - 2020 (USD Million) TABLE 27 Asia Pacific other biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 28 RoW biopsy devices market, by product, 2012 - 2020 (USD Million) TABLE 29 RoW needle based biopsy guns' market, by product, 2012 - 2020 (USD Million) TABLE 30 RoW biopsy guidance systems market, by product, 2012 - 2020 (USD Million) TABLE 31 RoW biopsy needles market, by product, 2012 - 2020 (USD Million) TABLE 32 RoW biopsy forceps market, by product, 2012 - 2020 (USD Million) TABLE 33 RoW other biopsy devices market, by product, 2012 - 2020 (USD Million)
List of Figures FIG. 1 Biopsy devices: Market segmentation FIG. 2 Global biopsy devices market, 2012 - 2020 (USD Million) FIG. 3 Biopsy devices: Market dynamics FIG. 4 Global population growth, by age-group, 2012 - 2020 (Million) FIG. 5 Global population growth, by age-group, 2012 - 2020 (Million) FIG. 6 Key Opportunities Prioritized FIG. 7 Biopsy devices market - Porter's analysis FIG. 8 Biopsy devices market - PESTEL analysis FIG. 9 Biopsy devices: Company market share analysis, 2013 FIG. 10 Biopsy devices market share by product, 2013 & 2020 FIG. 11 Global needle based biopsy guns market, 2012 - 2020 (USD Million) FIG. 12 Global vacuum-assisted biopsy (VAB) devices market, 2012 - 2020 (USD Million) FIG. 13 Global fine needle aspiration biopsy (FNAB) devices market, 2012 - 2020 (USD Million) FIG. 14 Global core needle biopsy (CNB) devices market, 2012 - 2020 (USD Million) FIG. 15 Global biopsy guidance systems market, 2012 - 2020 (USD Million) FIG. 16 Global manual guidance system market, 2012 - 2020 (USD Million) FIG. 17 Global Robotic market, 2012 - 2020 (USD Million) FIG. 18 Global disposable biopsy needles market, 2012 - 2020 (USD Million) FIG. 19 Global reusable biopsy needles market, 2012 - 2020 (USD Million) FIG. 20 Global general biopsy forceps market, 2012 - 2020 (USD Million) FIG. 21 Global hot biopsy forceps market, 2012 - 2020 (USD Million) FIG. 22 Global biopsy brushes market, 2012 - 2020 (USD Million) FIG. 23 Global biopsy curettes market, 2012 - 2020 (USD Million) FIG. 24 Global biopsy punches market, 2012 - 2020 (USD Million) FIG. 25 Biopsy devices market share, by region, 2013 & 2020 FIG. 26 North America biopsy devices market, 2012 - 2020 (USD Million) FIG. 27 Europe biopsy devices market, 2012 - 2020 (USD Million) FIG. 28 Asia Pacific biopsy devices market, 2012 - 2020 (USD Million) FIG. 29 RoW biopsy devices market, 2012 - 2020 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.